Angels’ Neeson fighting cancer again

The Angels frontman Doc Neeson is fighting cancer for a second time, he’s confirmed – but he remains as determined as ever to beat the disease.

He announced in 2013 that he’d been diagnosed with a brain tumour, and vowed he’d be among the 20% of victims who’d survive. His statement came just days before Angels bassist Chris Bailey retired from the band to deal with jaw cancer. He died last April.

Neeson tells ABC: “The news is grim – but some people can get through this, and that’s the way I try to think about things. I’m looking forward optimistically to the future.”

He reveals he was given 18 months to live when first diagnosed, saying: “It was a shock when someone put a use-by date on me, but I still hung on to a shred of hope that I’d get back on stage at some point.”

The first tumour was successfully removed, followed by a regime of radiotherapy and chemotherapy that caused him to sleep for 20 hours a day. A benefit show called Rock For Doc was held last year.

Friend and colleague Jimmy Barnes said at the event: “It’s a sad thing that we wait until somebody is sick to let them know we love them. He’s done some of the most inspirational gigs I’ve ever seen. He’s a great guy.”

Neeson was recently awarded the Order Of Australia Medal and admitted: “I felt a bit kind of humble. I haven’t saved any lives. I feel honoured to be in that company.”

Freelance Online News Contributor

Not only is one-time online news editor Martin an established rock journalist and drummer, but he’s also penned several books on music history, including SAHB Story: The Tale of the Sensational Alex Harvey Band, a band he once managed, and the best-selling Apollo Memories about the history of the legendary and infamous Glasgow Apollo. Martin has written for Classic Rock and Prog and at one time had written more articles for Louder than anyone else (we think he's second now). He’s appeared on TV and when not delving intro all things music, can be found travelling along the UK’s vast canal network.